DISPATCHES FROM INTERPHEX

Kemwell Talks Expansion and Approvals in India and the US

Kemwell spoke to Outsourcing-Pharma.com at Interphex, New York

At this year’s Interphex, Kemwell Biopharma spoke to Outsourcing-Pharma.com about recent expansions in both India and the US.

Kemwell’s Director of Corporate Development Christian Ahlmark, spoke about the FDA approval at its manufacturing plant in Bangalore, India as well as the biologics facility - also in Bangalore – that recently opened its doors.

Kemwell recently announced 1500 sq ft of analytical lab space had been added in response to a contract by a major manufacturer.

However, it is not just India where Kemwell has been expanding. Ahlmark said the company was expanding its “lab footprint” on the East Coast in order to offer its current customers formulation development, expertise, analyticals and project management services.

Related News

Kemwell buys Cirrus

Kemwell Acquires US Delivery Development Firm

Kemwell's new Bangalore facility to service first Western biopharma

Kemwell opens doors to West with first mAb deal from Indian plant

Kemwell inks first deal at new Indian biomanufacturing plant

Kemwell inks first deal at new Indian biomanufacturing plant

Kemwell CEO discusses green manufacturing

Kemwell CEO says environmental efforts are worth the cost

Kemwell adds freeze-drying tech

Kemwell adds freeze-drying tech at Bangalore biologics plant

Experts: Quality and IP issues driving sponsors away from Indian CMOs

Quality and IP issues driving sponsors away from Indian CMOs, experts say

Kemwell's oral solid dose plant approved following joint inspection

Kemwell's oral solid dose plant approved following joint European inspection

Kemwell announces Cirrus to produce trial supplies in 'flexi suite'

Kemwell announces Cirrus to produce trial supplies in 'flexi suite'

Big Pharma: outsourcing or investing in-house?

CMO use to grow despite Big Biopharma's in-house spend, say experts

Biologics demand a boon for CMOs, but a shift to single-use could see more competition

Bio-CMO sector to grow over 40% on Big Biopharma's burgeoning pipelines

Kemwell plant passes inspection

Kemwell plant passes US FDA inspection

Kemwell and Boehringer set to finish biologics plant in India

Kemwell and Boehringer set to finish biologics plant in India

Kemwell adds cGMP pilot plant to expand capabilities in India

Dedicated Analytical Expansion Could Target New Clients, says Kemwell

Dedicated Analytical Expansion Could Target New Clients, says Kemwell